How is chronic myelomonocytic leukemia staged?
Doctors often group cancers into different stages based on the size of the tumor and how far the cancer has spread from the original site in the body. The stage of a cancer can help predict the outlook for a cancer. Often, the stage of a cancer is used to decide which treatment is needed.
Chronic myelomonocytic (MY-eh-loh-MAH-noh-SIH-tik) leukemia (CMML) is a disease of the bone marrow. It cannot be staged by looking at the size of a tumor like some other cancers. Instead, CMML is split into 2 groups based on cell counts in the blood and bone marrow:
- CMML-1: Blasts make up less than 5% of white cells in the blood and less than 10% of the cells in the bone marrow.
- CMML-2: Blasts make up 5% to 20% of the white cells in the blood, or they make up 10% to 20% of the cells in the bone marrow.
Last Medical Review: 01/19/2014
Last Revised: 02/17/2016
- What Is Leukemia - Chronic Myelomonocytic (CMML)?
- Causes, Risk Factors, and Prevention
- Early Detection, Diagnosis, and Staging
- Treating Leukemia - Chronic Myelomonocytic (CMML)
- After Treatment
- Talking With Your Doctor
- What`s New in Leukemia - Chronic Myelomonocytic (CMML) Research?
- Other Resources and References